ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmacology Discovery Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-26O17177
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmacology Discovery Service Market Research Report 2024
BUY CHAPTERS

Global Pharmacology Discovery Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-26O17177
Report
October 2025
Pages:154
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ichor Life Sciences, Inc
Nuvisan
Porsolt
Charles River Laboratories
Eurofins Discovery
LabCorp
Bioduro-Sundia
Creative-Biolabs
BRF
WuXi AppTec
Dalriada
Sygnature Discovery
Pharmaron
ChemPartner
GenScript ProBio
NuChem Sciences Inc

Pharmacology Discovery Service Market

The global Pharmacology Discovery Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Pharmacology Discovery Service is a service focused on drug discovery and development, which covers a wide range of aspects from drug target identification, drug candidate screening, drug mechanism of action studies to preclinical evaluation. Pharmacology Discovery Service aims to accelerate the drug discovery and development process through scientific methods and technologies, and to provide the pharmaceutical industry with high-quality information on drug candidates and drug mechanism of action.
From a downstream perspective, Cardiovascular Disease accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmacology Discovery Service leading manufacturers including Ichor Life Sciences, Inc, NUVISAN, Porsolt, Charles River Laboratories, Eurofins Discovery, Labcorp, BioDuro-Sundia, Creative Biolabs, BRF, WuXi AppTec, etc., dominate supply; the top five capture approximately % of global revenue, with Ichor Life Sciences, Inc leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmacology Discovery Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pharmacology Discovery Service Market Report

Report Metric Details
Report Name Pharmacology Discovery Service Market
Segment by Type
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ichor Life Sciences, Inc, NUVISAN, Porsolt, Charles River Laboratories, Eurofins Discovery, Labcorp, BioDuro-Sundia, Creative Biolabs, BRF, WuXi AppTec, Dalriada, Sygnature Discovery, Pharmaron, ChemPartner, NuChem Sciences Inc, Genscript ProBio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pharmacology Discovery Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pharmacology Discovery Service Market report?

Ans: The main players in the Pharmacology Discovery Service Market are Ichor Life Sciences, Inc, NUVISAN, Porsolt, Charles River Laboratories, Eurofins Discovery, Labcorp, BioDuro-Sundia, Creative Biolabs, BRF, WuXi AppTec, Dalriada, Sygnature Discovery, Pharmaron, ChemPartner, NuChem Sciences Inc, Genscript ProBio

What are the Application segmentation covered in the Pharmacology Discovery Service Market report?

Ans: The Applications covered in the Pharmacology Discovery Service Market report are Cardiovascular Disease, Eye Diseases, Autoimmune Diseases, Musculoskeletal Diseases, Other

What are the Type segmentation covered in the Pharmacology Discovery Service Market report?

Ans: The Types covered in the Pharmacology Discovery Service Market report are In Vivo Disease Model, Cell Based Assays Service, Drug Discovery Service, Others

Recommended Reports

Drug Discovery Services

Pharmaceutical Testing

Clinical & Diagnostic Services

1 Study Coverage
1.1 Introduction to Pharmacology Discovery Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmacology Discovery Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 In Vivo Disease Model
1.2.3 Cell Based Assays Service
1.2.4 Drug Discovery Service
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Pharmacology Discovery Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Disease
1.3.3 Eye Diseases
1.3.4 Autoimmune Diseases
1.3.5 Musculoskeletal Diseases
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmacology Discovery Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmacology Discovery Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pharmacology Discovery Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pharmacology Discovery Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 In Vivo Disease Model Market Size by Players
3.3.2 Cell Based Assays Service Market Size by Players
3.3.3 Drug Discovery Service Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Pharmacology Discovery Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmacology Discovery Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmacology Discovery Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pharmacology Discovery Service Market Size by Type (2020-2031)
6.4 North America Pharmacology Discovery Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmacology Discovery Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pharmacology Discovery Service Market Size by Type (2020-2031)
7.4 Europe Pharmacology Discovery Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmacology Discovery Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pharmacology Discovery Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Pharmacology Discovery Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pharmacology Discovery Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pharmacology Discovery Service Market Size by Type (2020-2031)
9.4 Central and South America Pharmacology Discovery Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmacology Discovery Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pharmacology Discovery Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Pharmacology Discovery Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmacology Discovery Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Ichor Life Sciences, Inc
11.1.1 Ichor Life Sciences, Inc Corporation Information
11.1.2 Ichor Life Sciences, Inc Business Overview
11.1.3 Ichor Life Sciences, Inc Pharmacology Discovery Service Product Features and Attributes
11.1.4 Ichor Life Sciences, Inc Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.1.5 Ichor Life Sciences, Inc Pharmacology Discovery Service Revenue by Product in 2024
11.1.6 Ichor Life Sciences, Inc Pharmacology Discovery Service Revenue by Application in 2024
11.1.7 Ichor Life Sciences, Inc Pharmacology Discovery Service Revenue by Geographic Area in 2024
11.1.8 Ichor Life Sciences, Inc Pharmacology Discovery Service SWOT Analysis
11.1.9 Ichor Life Sciences, Inc Recent Developments
11.2 NUVISAN
11.2.1 NUVISAN Corporation Information
11.2.2 NUVISAN Business Overview
11.2.3 NUVISAN Pharmacology Discovery Service Product Features and Attributes
11.2.4 NUVISAN Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.2.5 NUVISAN Pharmacology Discovery Service Revenue by Product in 2024
11.2.6 NUVISAN Pharmacology Discovery Service Revenue by Application in 2024
11.2.7 NUVISAN Pharmacology Discovery Service Revenue by Geographic Area in 2024
11.2.8 NUVISAN Pharmacology Discovery Service SWOT Analysis
11.2.9 NUVISAN Recent Developments
11.3 Porsolt
11.3.1 Porsolt Corporation Information
11.3.2 Porsolt Business Overview
11.3.3 Porsolt Pharmacology Discovery Service Product Features and Attributes
11.3.4 Porsolt Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.3.5 Porsolt Pharmacology Discovery Service Revenue by Product in 2024
11.3.6 Porsolt Pharmacology Discovery Service Revenue by Application in 2024
11.3.7 Porsolt Pharmacology Discovery Service Revenue by Geographic Area in 2024
11.3.8 Porsolt Pharmacology Discovery Service SWOT Analysis
11.3.9 Porsolt Recent Developments
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Corporation Information
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Pharmacology Discovery Service Product Features and Attributes
11.4.4 Charles River Laboratories Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.4.5 Charles River Laboratories Pharmacology Discovery Service Revenue by Product in 2024
11.4.6 Charles River Laboratories Pharmacology Discovery Service Revenue by Application in 2024
11.4.7 Charles River Laboratories Pharmacology Discovery Service Revenue by Geographic Area in 2024
11.4.8 Charles River Laboratories Pharmacology Discovery Service SWOT Analysis
11.4.9 Charles River Laboratories Recent Developments
11.5 Eurofins Discovery
11.5.1 Eurofins Discovery Corporation Information
11.5.2 Eurofins Discovery Business Overview
11.5.3 Eurofins Discovery Pharmacology Discovery Service Product Features and Attributes
11.5.4 Eurofins Discovery Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.5.5 Eurofins Discovery Pharmacology Discovery Service Revenue by Product in 2024
11.5.6 Eurofins Discovery Pharmacology Discovery Service Revenue by Application in 2024
11.5.7 Eurofins Discovery Pharmacology Discovery Service Revenue by Geographic Area in 2024
11.5.8 Eurofins Discovery Pharmacology Discovery Service SWOT Analysis
11.5.9 Eurofins Discovery Recent Developments
11.6 Labcorp
11.6.1 Labcorp Corporation Information
11.6.2 Labcorp Business Overview
11.6.3 Labcorp Pharmacology Discovery Service Product Features and Attributes
11.6.4 Labcorp Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.6.5 Labcorp Recent Developments
11.7 BioDuro-Sundia
11.7.1 BioDuro-Sundia Corporation Information
11.7.2 BioDuro-Sundia Business Overview
11.7.3 BioDuro-Sundia Pharmacology Discovery Service Product Features and Attributes
11.7.4 BioDuro-Sundia Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.7.5 BioDuro-Sundia Recent Developments
11.8 Creative Biolabs
11.8.1 Creative Biolabs Corporation Information
11.8.2 Creative Biolabs Business Overview
11.8.3 Creative Biolabs Pharmacology Discovery Service Product Features and Attributes
11.8.4 Creative Biolabs Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.8.5 Creative Biolabs Recent Developments
11.9 BRF
11.9.1 BRF Corporation Information
11.9.2 BRF Business Overview
11.9.3 BRF Pharmacology Discovery Service Product Features and Attributes
11.9.4 BRF Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.9.5 BRF Recent Developments
11.10 WuXi AppTec
11.10.1 WuXi AppTec Corporation Information
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec Pharmacology Discovery Service Product Features and Attributes
11.10.4 WuXi AppTec Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Dalriada
11.11.1 Dalriada Corporation Information
11.11.2 Dalriada Business Overview
11.11.3 Dalriada Pharmacology Discovery Service Product Features and Attributes
11.11.4 Dalriada Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.11.5 Dalriada Recent Developments
11.12 Sygnature Discovery
11.12.1 Sygnature Discovery Corporation Information
11.12.2 Sygnature Discovery Business Overview
11.12.3 Sygnature Discovery Pharmacology Discovery Service Product Features and Attributes
11.12.4 Sygnature Discovery Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.12.5 Sygnature Discovery Recent Developments
11.13 Pharmaron
11.13.1 Pharmaron Corporation Information
11.13.2 Pharmaron Business Overview
11.13.3 Pharmaron Pharmacology Discovery Service Product Features and Attributes
11.13.4 Pharmaron Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.13.5 Pharmaron Recent Developments
11.14 ChemPartner
11.14.1 ChemPartner Corporation Information
11.14.2 ChemPartner Business Overview
11.14.3 ChemPartner Pharmacology Discovery Service Product Features and Attributes
11.14.4 ChemPartner Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.14.5 ChemPartner Recent Developments
11.15 NuChem Sciences Inc
11.15.1 NuChem Sciences Inc Corporation Information
11.15.2 NuChem Sciences Inc Business Overview
11.15.3 NuChem Sciences Inc Pharmacology Discovery Service Product Features and Attributes
11.15.4 NuChem Sciences Inc Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.15.5 NuChem Sciences Inc Recent Developments
11.16 Genscript ProBio
11.16.1 Genscript ProBio Corporation Information
11.16.2 Genscript ProBio Business Overview
11.16.3 Genscript ProBio Pharmacology Discovery Service Product Features and Attributes
11.16.4 Genscript ProBio Pharmacology Discovery Service Revenue and Gross Margin (2020-2025)
11.16.5 Genscript ProBio Recent Developments
12 Pharmacology Discovery ServiceIndustry Chain Analysis
12.1 Pharmacology Discovery Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmacology Discovery Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmacology Discovery Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Ichor Life Sciences, Inc
Nuvisan
Porsolt
Charles River Laboratories
Eurofins Discovery
LabCorp
Bioduro-Sundia
Creative-Biolabs
BRF
WuXi AppTec
Dalriada
Sygnature Discovery
Pharmaron
ChemPartner
GenScript ProBio
NuChem Sciences Inc
List of Tables
 Table 1. Global Pharmacology Discovery Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pharmacology Discovery Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pharmacology Discovery Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pharmacology Discovery Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pharmacology Discovery Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Pharmacology Discovery Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Pharmacology Discovery Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Pharmacology Discovery Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacology Discovery Service as of 2024)
 Table 11. Global Pharmacology Discovery Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Pharmacology Discovery Service Companies Headquarters
 Table 13. Global Pharmacology Discovery Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Pharmacology Discovery Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Pharmacology Discovery Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Pharmacology Discovery Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Pharmacology Discovery Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Pharmacology Discovery Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Pharmacology Discovery Service Growth Accelerators and Market Barriers
 Table 25. North America Pharmacology Discovery Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Pharmacology Discovery Service Growth Accelerators and Market Barriers
 Table 27. Europe Pharmacology Discovery Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Pharmacology Discovery Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Pharmacology Discovery Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Pharmacology Discovery Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Pharmacology Discovery Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Pharmacology Discovery Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Pharmacology Discovery Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Ichor Life Sciences, Inc Corporation Information
 Table 35. Ichor Life Sciences, Inc Description and Major Businesses
 Table 36. Ichor Life Sciences, Inc Product Features and Attributes
 Table 37. Ichor Life Sciences, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Ichor Life Sciences, Inc Revenue Proportion by Product in 2024
 Table 39. Ichor Life Sciences, Inc Revenue Proportion by Application in 2024
 Table 40. Ichor Life Sciences, Inc Revenue Proportion by Geographic Area in 2024
 Table 41. Ichor Life Sciences, Inc Pharmacology Discovery Service SWOT Analysis
 Table 42. Ichor Life Sciences, Inc Recent Developments
 Table 43. NUVISAN Corporation Information
 Table 44. NUVISAN Description and Major Businesses
 Table 45. NUVISAN Product Features and Attributes
 Table 46. NUVISAN Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. NUVISAN Revenue Proportion by Product in 2024
 Table 48. NUVISAN Revenue Proportion by Application in 2024
 Table 49. NUVISAN Revenue Proportion by Geographic Area in 2024
 Table 50. NUVISAN Pharmacology Discovery Service SWOT Analysis
 Table 51. NUVISAN Recent Developments
 Table 52. Porsolt Corporation Information
 Table 53. Porsolt Description and Major Businesses
 Table 54. Porsolt Product Features and Attributes
 Table 55. Porsolt Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Porsolt Revenue Proportion by Product in 2024
 Table 57. Porsolt Revenue Proportion by Application in 2024
 Table 58. Porsolt Revenue Proportion by Geographic Area in 2024
 Table 59. Porsolt Pharmacology Discovery Service SWOT Analysis
 Table 60. Porsolt Recent Developments
 Table 61. Charles River Laboratories Corporation Information
 Table 62. Charles River Laboratories Description and Major Businesses
 Table 63. Charles River Laboratories Product Features and Attributes
 Table 64. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Charles River Laboratories Revenue Proportion by Product in 2024
 Table 66. Charles River Laboratories Revenue Proportion by Application in 2024
 Table 67. Charles River Laboratories Revenue Proportion by Geographic Area in 2024
 Table 68. Charles River Laboratories Pharmacology Discovery Service SWOT Analysis
 Table 69. Charles River Laboratories Recent Developments
 Table 70. Eurofins Discovery Corporation Information
 Table 71. Eurofins Discovery Description and Major Businesses
 Table 72. Eurofins Discovery Product Features and Attributes
 Table 73. Eurofins Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Eurofins Discovery Revenue Proportion by Product in 2024
 Table 75. Eurofins Discovery Revenue Proportion by Application in 2024
 Table 76. Eurofins Discovery Revenue Proportion by Geographic Area in 2024
 Table 77. Eurofins Discovery Pharmacology Discovery Service SWOT Analysis
 Table 78. Eurofins Discovery Recent Developments
 Table 79. Labcorp Corporation Information
 Table 80. Labcorp Description and Major Businesses
 Table 81. Labcorp Product Features and Attributes
 Table 82. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Labcorp Recent Developments
 Table 84. BioDuro-Sundia Corporation Information
 Table 85. BioDuro-Sundia Description and Major Businesses
 Table 86. BioDuro-Sundia Product Features and Attributes
 Table 87. BioDuro-Sundia Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. BioDuro-Sundia Recent Developments
 Table 89. Creative Biolabs Corporation Information
 Table 90. Creative Biolabs Description and Major Businesses
 Table 91. Creative Biolabs Product Features and Attributes
 Table 92. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Creative Biolabs Recent Developments
 Table 94. BRF Corporation Information
 Table 95. BRF Description and Major Businesses
 Table 96. BRF Product Features and Attributes
 Table 97. BRF Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. BRF Recent Developments
 Table 99. WuXi AppTec Corporation Information
 Table 100. WuXi AppTec Description and Major Businesses
 Table 101. WuXi AppTec Product Features and Attributes
 Table 102. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. WuXi AppTec Recent Developments
 Table 104. Dalriada Corporation Information
 Table 105. Dalriada Description and Major Businesses
 Table 106. Dalriada Product Features and Attributes
 Table 107. Dalriada Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Dalriada Recent Developments
 Table 109. Sygnature Discovery Corporation Information
 Table 110. Sygnature Discovery Description and Major Businesses
 Table 111. Sygnature Discovery Product Features and Attributes
 Table 112. Sygnature Discovery Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Sygnature Discovery Recent Developments
 Table 114. Pharmaron Corporation Information
 Table 115. Pharmaron Description and Major Businesses
 Table 116. Pharmaron Product Features and Attributes
 Table 117. Pharmaron Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Pharmaron Recent Developments
 Table 119. ChemPartner Corporation Information
 Table 120. ChemPartner Description and Major Businesses
 Table 121. ChemPartner Product Features and Attributes
 Table 122. ChemPartner Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. ChemPartner Recent Developments
 Table 124. NuChem Sciences Inc Corporation Information
 Table 125. NuChem Sciences Inc Description and Major Businesses
 Table 126. NuChem Sciences Inc Product Features and Attributes
 Table 127. NuChem Sciences Inc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. NuChem Sciences Inc Recent Developments
 Table 129. Genscript ProBio Corporation Information
 Table 130. Genscript ProBio Description and Major Businesses
 Table 131. Genscript ProBio Product Features and Attributes
 Table 132. Genscript ProBio Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Genscript ProBio Recent Developments
 Table 134. Raw Materials Key Suppliers
 Table 135. Distributors List
 Table 136. Market Trends and Market Evolution
 Table 137. Market Drivers and Opportunities
 Table 138. Market Challenges, Risks, and Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmacology Discovery Service Product Picture
 Figure 2. Global Pharmacology Discovery Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. In Vivo Disease Model Product Picture
 Figure 4. Cell Based Assays Service Product Picture
 Figure 5. Drug Discovery Service Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Pharmacology Discovery Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Cardiovascular Disease
 Figure 9. Eye Diseases
 Figure 10. Autoimmune Diseases
 Figure 11. Musculoskeletal Diseases
 Figure 12. Other
 Figure 13. Pharmacology Discovery Service Report Years Considered
 Figure 14. Global Pharmacology Discovery Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 16. Global Pharmacology Discovery Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 17. Global Pharmacology Discovery Service Revenue Market Share by Region (2020-2031)
 Figure 18. Global Pharmacology Discovery Service Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. In Vivo Disease Model Revenue Market Share by Player in 2024
 Figure 21. Cell Based Assays Service Revenue Market Share by Player in 2024
 Figure 22. Drug Discovery Service Revenue Market Share by Player in 2024
 Figure 23. Others Revenue Market Share by Player in 2024
 Figure 24. Global Pharmacology Discovery Service Revenue Market Share by Type (2020-2031)
 Figure 25. Global Pharmacology Discovery Service Revenue Market Share by Application (2020-2031)
 Figure 26. North America Pharmacology Discovery Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Players Pharmacology Discovery Service Revenue (US$ Million) in 2024
 Figure 28. North America Pharmacology Discovery Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 29. North America Pharmacology Discovery Service Revenue (US$ Million) by Application (2020-2031)
 Figure 30. US Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 31. Canada Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 32. Mexico Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 33. Europe Pharmacology Discovery Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 34. Europe Top 5 Players Pharmacology Discovery Service Revenue (US$ Million) in 2024
 Figure 35. Europe Pharmacology Discovery Service Revenue (US$ Million) by Type (2020-2031)
 Figure 36. Europe Pharmacology Discovery Service Revenue (US$ Million) by Application (2020-2031)
 Figure 37. Germany Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 38. France Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 39. U.K. Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 40. Italy Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 41. Russia Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Pharmacology Discovery Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific Top 8 Players Pharmacology Discovery Service Revenue (US$ Million) in 2024
 Figure 44. Asia-Pacific Pharmacology Discovery Service Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Asia-Pacific Pharmacology Discovery Service Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Indonesia Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Japan Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 48. South Korea Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Australia Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 50. India Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Indonesia Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 52. Vietnam Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 53. Malaysia Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 54. Philippines Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 55. Singapore Pharmacology Discovery Service Revenue (2020-2031) & (US$ Million)
 Figure 56. Central and South America Pharmacology Discovery Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Central and South America Top 5 Players Pharmacology Discovery Service Revenue (US$ Million) in 2024
 Figure 58. Central and South America Pharmacology Discovery Service Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Central and South America Pharmacology Discovery Service Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Brazil Pharmacology Discovery Service Revenue (2020-2025) & (US$ Million)
 Figure 61. Argentina Pharmacology Discovery Service Revenue (2020-2025) & (US$ Million)
 Figure 62. Middle East and Africa Pharmacology Discovery Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Middle East and Africa Top 5 Players Pharmacology Discovery Service Revenue (US$ Million) in 2024
 Figure 64. South America Pharmacology Discovery Service Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Middle East and Africa Pharmacology Discovery Service Revenue (US$ Million) by Application (2020-2031)
 Figure 66. GCC Countries Pharmacology Discovery Service Revenue (2020-2025) & (US$ Million)
 Figure 67. Israel Pharmacology Discovery Service Revenue (2020-2025) & (US$ Million)
 Figure 68. Egypt Pharmacology Discovery Service Revenue (2020-2025) & (US$ Million)
 Figure 69. South Africa Pharmacology Discovery Service Revenue (2020-2025) & (US$ Million)
 Figure 70. Pharmacology Discovery Service Industry Chain Mapping
 Figure 71. Channels of Distribution (Direct Vs Distribution)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Drug Discovery Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacokinetic Service Market Research Report 2025
Global Drug Discovery Software Market Insights Forecast to 2030
Global Pharmaceutical Characterization Service Market Research Report 2025
Oncology Drug Discovery Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacokinetic Research Service Market Research Report 2024
Outsourced Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Bioanalysis Services Market Research Report 2025
Global Innovative Drug Commercialization Service Platform Market Research Report 2024
Drug Discovery and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Testing Services Market Research Report 2025
Global In Vivo Pharmacology Service Market Research Report 2024
Global Drug Safety Testing Market Research Report 2025
Global High Throughput Screening Services for Drug Discovery Market Research Report 2024
Global Drug Interaction Testing Service Market Research Report 2025
Computer Aided Drug Discovery CADD Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Preclinical Research Service Market Research Report 2024
Global Clinical Safety and Pharmacovigilance Services Market Research Report 2024
Global Antibody Epitope Discovery Service Market Research Report 2024
Global Pharmacokinetics Testing Service Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions